|
Index of reports
> All cases (53)
> Cases with Myocardial Infarction (8)
Below is the selection of adverse event reports related to Tricor (Fenofibrate) that includes all cases where reactions include myocardial infarction.
Adverse event in male receiving Tricor (Fenofibrate)
Reported by a physician from United States on 2007-03-09
Patient: male, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Medication Error, Drug Interaction, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Tricor
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Multivitamins
Indication: Drug USE FOR Unknown Indication
End date: 2006-06-11
Risperidone
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient possibly interacting with the suspect drug:
Pioglitazone HCL
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Nicotinic Acid
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Nicotinic Acid
Indication: Blood Cholesterol Increased
Bupropion Hydrochloride
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Venlafaxine Hydrochloride
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Lorazepam
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Trazodone HCL
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Atenolol
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Digoxin
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Glucophage
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glipizide
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Insulin Glargine
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Insulin Glargine
End date: 2006-06-09
Atorvastatin
Indication: Drug USE FOR Unknown Indication
Adverse event in 65 year old male receiving Tricor (Fenofibrate)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-26
Patient: 65 year old male
Adverse reactions / side effects: Ultrasound Scan Abnormal, Alanine Aminotransferase Increased, Incorrect Dose Administered, Skin Disorder, High Density Lipoprotein Decreased, Flushing, Haemoglobin Decreased, Glycosylated Haemoglobin Increased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Depressed Level of Consciousness, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Effexor XR
Dosage: 150 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day;sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day;sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df;
End date: 2006-06-11
Tenormin
Dosage: 1000 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day;po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg; po
Administration route: Oral
Multi-Vitamins
Dosage: df;
Adverse event in 65 year old male receiving Tricor (Fenofibrate)
Reported by a physician from United States on 2007-02-16
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg qd po
Administration route: Oral
Indication: Depression
Effexor
Dosage: 150 mg daily po
Administration route: Oral
Indication: Depression
Lorazepam
Dosage: 2 mg qd po
Administration route: Oral
Indication: Depression
Trazodone HCL
Dosage: 200 mg qd po
Administration route: Oral
Indication: Depression
Tenormin
Dosage: 100 mg qd po
Administration route: Oral
Indication: Tachyarrhythmia
Lanoxin
Dosage: 0.375 mg qd po
Administration route: Oral
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Glucotrol XL
Dosage: 10 mg qd po
Administration route: Oral
Actos
Dosage: 45 mg qd po
Administration route: Oral
Tricor
Dosage: 160 mg qd po
Administration route: Oral
Lantus
Dosage: 70 qd sc
Start date: 2006-06-09
Lipitor
Vitamin CAP
Risperdal
Dosage: 3 mg po
Administration route: Oral
Adverse event in male receiving Tricor (Fenofibrate)
Reported by a physician from United States on 2007-02-09
Patient: male, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Medication Error, Drug Interaction, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Tricor
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Vitamin CAP
Indication: Drug USE FOR Unknown Indication
End date: 2006-06-11
Risperdal
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient possibly interacting with the suspect drug:
Pioglitazone HCL
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Nicotinic Acid
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-09
End date: 2006-06-11
Nicotinic Acid
Indication: Blood Cholesterol Increased
Bupropion Hydrochloride
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Venlafaxine Hydrochloride
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Lorazepam
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Trazodone HCL
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Atenolol
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Digoxin
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Glucophage
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glipizide
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Insulin Glargine
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Insulin Glargine
End date: 2006-06-09
Atorvastatin Calcium
Indication: Drug USE FOR Unknown Indication
Adverse event in 65 year old male receiving Tricor (Fenofibrate)
Reported by a individual with unspecified qualification from United States on 2007-02-07
Patient: 65 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Pallor, High Density Lipoprotein Decreased, Hepatic Steatosis, Flushing, Haemoglobin Decreased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: Hypercholesterolaemia
Effexor XR
Dosage: 150 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 g q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df
End date: 2006-06-11
Tenormin
Dosage: 100 mg q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg po
Administration route: Oral
Vitamin CAP
Dosage: df
Adverse event in 65 year old male receiving Tricor (Fenofibrate)
Reported by a physician from United States on 2007-01-31
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Actos
Dosage: 45 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2003-07-01
End date: 2006-06-11
Niaspan
Dosage: 1000 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Effexor
Dosage: 150 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Lorazepam
Dosage: 2 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tenormin
Dosage: 100 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Glucophage
Dosage: 1000 mg, 2 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Tricor
Dosage: 160 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Lantus
Dosage: see image
Indication: Diabetes Mellitus
End date: 2006-06-09
Lantus
Dosage: see image
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lipitor
End date: 2006-06-11
Multivitamin
End date: 2006-06-11
Risperdal
Dosage: 3 mg, per oral
Administration route: Oral
End date: 2006-06-11
Adverse event in male receiving Tricor (Fenofibrate)
Reported by a physician from United States on 2007-01-31
Patient: male, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Medication Error, Drug Interaction, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Tricor
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Vitamin CAP
Indication: Drug USE FOR Unknown Indication
End date: 2006-06-11
Risperdal
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient possibly interacting with the suspect drug:
Pioglitazone HCL
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Nicotinic Acid
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-09
End date: 2006-06-11
Nicotinic Acid
Indication: Blood Cholesterol Increased
Bupropion Hydrochloride
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Venlafaxine Hydrochloride
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Lorazepam
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Trazodone HCL
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Atenolol
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Digoxin
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Glucophage(glucophage)
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glipizide
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Insulin Glargine
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Insulin Glargine
End date: 2006-06-09
Atorvastatin Calcium
Indication: Drug USE FOR Unknown Indication
Adverse event in 65 year old male receiving Tricor (Fenofibrate)
Reported by a consumer/non-health professional from United States on 2007-01-29
Patient: 65 year old male
Adverse reactions / side effects: Flushing, Medication Error, Drug Interaction, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Wellbutrin
Dosage: 300mg per day
Administration route: Oral
Indication: Depression
Lanoxin
Dosage: .375mg per day
Administration route: Oral
Indication: Tachyarrhythmia
Niaspan
Dosage: 1000mg single dose
Administration route: Oral
Start date: 2006-07-11
End date: 2006-07-11
Trazodone HCL
Dosage: 200mg per day
Administration route: Oral
Indication: Depression
Tenormin
Dosage: 100mg per day
Administration route: Oral
Indication: Tachyarrhythmia
Glucophage
Dosage: 1000mg twice per day
Administration route: Oral
Indication: Diabetes Mellitus
Glucotrol XL
Dosage: 10mg per day
Administration route: Oral
Indication: Diabetes Mellitus
Actos
Dosage: 45mg per day
Administration route: Oral
Indication: Diabetes Mellitus
Tricor
Dosage: 160mg per day
Administration route: Oral
Lantus
Dosage: 70u per day
Indication: Diabetes Mellitus
Lipitor
Indication: Drug USE FOR Unknown Indication
Effexor
Dosage: 150mg per day
Administration route: Oral
Indication: Depression
Lorazepam
Dosage: 2mg per day
Administration route: Oral
Indication: Depression
Risperdal
Dosage: 3mg per day
Administration route: Oral
Multi-Vitamins
Other drugs received by patient: NO Concurrent Medications
|
